Evidence map›Paper›PMID 31313948›Full record

ArticleEnvironmental health perspectives2019

Oral Systemic Bioavailability of Bisphenol A and Bisphenol S in Pigs.

Véronique Gayrard, Marlène Z Lacroix, Flore C Grandin, Séverine H Collet, Hanna Mila, Catherine Viguié, Clémence A Gély, Blandine Rabozzi, Michèle Bouchard, Roger Léandri and 2 more

Abstract readComparative Study
In one paragraph

Article in Environmental health perspectives, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Enteric Nervous System Damage by Food Contaminants: A Pathway to Neurodegeneration?Comprehensive reviews in food science and food safety · 2026
    Pooled it
  2. Article
  3. Bisphenols and follicle function in farm species.The Journal of reproduction and development · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The intestinal microbiota as mediators between dietary contaminants and host health.Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Are BPA Substitutes as Obesogenic as BPA?International journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Véronique GayrardToxalim, Université de Toulouse, INRA (Institut National de la Recherche Agronomique), INP (Institut National Polytechnique de Toulouse)-ENVT (Ecole Nationale Vétérinaire de Toulouse), Toulouse France.
Marlène Z LacroixTherapeutic Innovations and Resistance (INTHERES), Université de Toulouse, INRA, ENVT, Toulouse, France.
Flore C GrandinToxalim, Université de Toulouse, INRA (Institut National de la Recherche Agronomique), INP (Institut National Polytechnique de Toulouse)-ENVT (Ecole Nationale Vétérinaire de Toulouse), Toulouse France.
Séverine H ColletToxalim, Université de Toulouse, INRA (Institut National de la Recherche Agronomique), INP (Institut National Polytechnique de Toulouse)-ENVT (Ecole Nationale Vétérinaire de Toulouse), Toulouse France.
Hanna MilaToxalim, Université de Toulouse, INRA (Institut National de la Recherche Agronomique), INP (Institut National Polytechnique de Toulouse)-ENVT (Ecole Nationale Vétérinaire de Toulouse), Toulouse France.
Catherine ViguiéToxalim, Université de Toulouse, INRA (Institut National de la Recherche Agronomique), INP (Institut National Polytechnique de Toulouse)-ENVT (Ecole Nationale Vétérinaire de Toulouse), Toulouse France.
Clémence A GélyToxalim, Université de Toulouse, INRA (Institut National de la Recherche Agronomique), INP (Institut National Polytechnique de Toulouse)-ENVT (Ecole Nationale Vétérinaire de Toulouse), Toulouse France.
Blandine RabozziToxalim, Université de Toulouse, INRA (Institut National de la Recherche Agronomique), INP (Institut National Polytechnique de Toulouse)-ENVT (Ecole Nationale Vétérinaire de Toulouse), Toulouse France.
Michèle BouchardDépartement de santé environnementale et santé au travail, Institut de recherche en santé publique de l'Université de Montréal (IRSPUM), Université de Montréal, Montréal, Canada.
Roger LéandriEA 3694 Human Fertility Research Group, Toulouse University Hospital, Toulouse, France.
Pierre-Louis ToutainTherapeutic Innovations and Resistance (INTHERES), Université de Toulouse, INRA, ENVT, Toulouse, France.
Nicole Picard-HagenToxalim, Université de Toulouse, INRA (Institut National de la Recherche Agronomique), INP (Institut National Polytechnique de Toulouse)-ENVT (Ecole Nationale Vétérinaire de Toulouse), Toulouse France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiven its hormonal activity, bisphenol S (BPS) as a substitute for bisphenol A (BPA) could actually increase the risk of endocrine disruption if its toxicokinetic (TK) properties, namely its oral availability and systemic persistency, were higher than those of BPA.

objectivesThe TK behavior of BPA and BPS was investigated by administering the two compounds by intravenous and oral routes in piglet, a known valid model for investigating oral TK.

methodsExperiments were conducted in piglets to evaluate the kinetics of BPA, BPS, and their glucuronoconjugated metabolites in plasma and urine after intravenous administration of BPA, BPS, and BPS glucuronide (BPSG) and gavage administration of BPA and BPS. A population semiphysiologically based TK model describing the disposition of BPA and BPS and their glucuronides was built from these data to estimate the key TK parameters that drive the internal exposure to active compounds.

resultsThe data indicated that almost all the BPS oral dose was absorbed and transported into the liver where only 41% of BPS was glucuronidated, leading to a systemic bioavailability of 57.4%. In contrast, only 77% of the oral dose of BPA was absorbed and underwent an extensive first-pass glucuronidation either in the gut (44%) or in the liver (53%), thus accounting for the low systemic bioavailability of BPA (0.50%). Due to the higher systemic availability of BPS, in comparison with BPA, and its lower plasma clearance (3.5 times lower), the oral BPS systemic exposure was on average about 250 times higher than for BPA for an equal oral molar dose of the two compounds.

conclusionGiven the similar digestive tracts of pigs and humans, our results suggest that replacing BPA with BPS will likely lead to increased internal exposure to an endocrine-active compound that would be of concern for human health. https://doi.org/10.1289/EHP4599.

Indexed as

Administration, IntravenousAdministration, OralAnimalsBenzhydryl CompoundsBiological AvailabilityBisphenol A CompoundsBisphenol S CompoundsEnvironmental PollutantsFemaleMalePhenolsSulfonesSus scrofaToxicokineticsBenzhydryl Compoundsbisphenol ABisphenol A Compoundsbisphenol SBisphenol S CompoundsEnvironmental PollutantsPhenolsSulfones

Identifiers

PMID31313948
PMCPMC6792350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.